Opus Genetics, Inc. (Nasdaq: IRD) (the "Company” or "Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

In a recent video interview with Applied Clinical Trials, Rob DiCicco, vice president of portfolio management at ...

Researchers receive UK recognition after developing self-calibrating imaging technology that improves precision in healthcare ...

A team of Nigerian scientists has earned international recognition after securing intellectual property protection in the ...

A flashback to one of my favorite designs—the Alignment Wrap—highlighting its unique structure, creative process, and timeless wearable style. #fashiondesign #wrap #creativework ...

Chris Gotterup won the 2026 John Deere Classic on Sunday for his fifth PGA Tour win. Here's a breakdown of what's in his ...

Instead of pushing mandates, leaders should build an office that actually delivers on the promise of stronger collaboration ...

A team of Nigerian scientists has secured intellectual property protection in the United Kingdom for a home-grown medical ...

A new laser-optical system uses 2,000 controllable beams to precisely position atoms, enabling key logic processes in a ...

The Oklahoma Turnpike Authority says design work on the 19-mile South Extension Turnpike is progressing ahead of schedule, ...

GPT-5.6 release date remains unconfirmed as June 22 opens the primary prediction window. OpenAI’s kindle-alpha cleared ...

Regulatory alignment with U.S. Food and Drug Administration (FDA) on key elements of NOV-ERA Phase 2b study design, including novel primary endpoint of endoscopic passability -- ...